drugset / Trial / NCT00059735

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

NCT00059735

Phase 2 Completed 30 enrolled Eisai Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.

Timeline

Start
2002-05
Primary completion
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject indisulam Small molecule Intravenous